Table 1.
Clinical characteristics of 8 cases with Diabetic Striate Syndrome.
| Case | Sex | Age (years) | Type of DM | Age of diabetes diagnosis | FBG on admission (mmol/l) | HbA1c levels (%) | Current medications | FBG before discharge (mmol/l) | Diabetes complications |
|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 74 | 2 | 67 | 8.6 | 14 | Lixisenatide, Humalog | 8.3 | DPN, DR |
| 2 | F | 82 | 2 | 62 | 8.2 | 8.7 | Pioglitazone, Actos | 7.1 | DPN, DR, DN |
| 3 | M | 50 | 2 | 44 | 11.9 | 15.5 | NovoRapid, Levemir | 5.3 | DPN, DR, ACI |
| 4 | F | 88 | 2 | 72 | 19.5 | 14.6 | NovoLog, Levemir. | 7.7 | DPN, DR |
| 5 | F | 81 | 2 | 58 | 6.7 | 11.2 | Glucotrol, Acarbose. | 5.3 | DPN, DR, DN, ACI |
| 6 | M | 69 | 2 | 49 | 6.3 | 11.3 | NovoMix 30R, Metformin | 6 | DPN, DR, DF |
| 7 | M | 86 | 2 | 85 | 5 | 9 | Repaglinide | 4.4 | DPN |
| 8 | F | 84 | 2 | 74 | 8.5 | 12.1 | Acarbose, Glipizide | 7.2 | DPN |
DM, Diabetes Mellitus; FBG, fasting blood glucose; F, female; M, male; DPN, diabetic peripheral neuropathy; DN, diabetic nephropathy; DR, diabetic retinopathy; DF, diabetic foot; ACI, acute cerebral infarction.